Ramgopal MN, Lalezari JP, Pires Dos Santos AG, Krishnan P, et al. Budigalimab, an anti-PD-1 inhibitor, for people living with HIV-1: a randomized, placebo-controlled phase 1b study. Nat Med 2025 Oct 15. doi: 10.1038/s41591-025-03993.
PMID: 41094034